Friday, August 21, 2020

Explained | Why USFDA has put plasma therapy for Covid-19 on hold and what it means for India

Explained | Why USFDA has put plasma therapy for Covid-19 on hold and what it means for India A group of top US health officials, including Anthony Fauci, have said that the emerging data on the treatment was too weak for the approval.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/explained-|-why-usfda-has-put-plasma-therapy-for-covid-19holdwhat-it-means-for-india_14201801.html

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...